• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA commissioner Robert Califf: Adcomm reforms coming, praises AI potential

cafead

Administrator
Staff member
  • cafead   Feb 01, 2024 at 11:43: AM
via In a fireside chat Wednesday afternoon, Food and Drug Administration Commissioner Robert Califf had a lot to say about the future of the agency.

Califf provided an update on the FDA’s hopes for its 2024 budget, the future of AI in healthcare, drug shortages and its ongoing reorganization process.

article source